Profile
ALGS VRTX REGN SGEN ARGX ALNY
Company Name Aligos Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $50.44M $130.72B $65.65B $43.15B $35.85B $35.25B
Employees 0.07K 6.10K 15.11K 3.26K 1.60K 2.23K
CEO Dr. Lawrence M. Blatt MBA, Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
ALGS VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
ALGS VRTX REGN SGEN ARGX ALNY
Last Close $6.48 $484.01 $610.64 $228.74 $590.06 $262.16
High 52 $45.62 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.35 $392.81 $610.21 $228.74 $356.01 $143.31
Price vs. 52 Week High -85.8 % -6.33 % -49.19 % 0 % -12.16 % -11.66 %
Price vs. 52 Week Low 1751.43 % 23.22 % 0.07 % 0 % 65.74 % 82.93 %
Total Return
ALGS VRTX REGN SGEN ARGX ALNY
1 Month Return -54.81 % -0.45 % -9.6 % 0 % -5.02 % 7.92 %
3 Month Return -85.08 % 18.89 % -14.97 % 0 % -5.03 % 11.9 %
6 Month Return -20.59 % 6.3 % -39.71 % 0 % 11.34 % -2.18 %
9 Month Return 1433.73 % 2.92 % -40.37 % 0 % 35.56 % 5.42 %
YTD Return -83.73 % 20.19 % -14.28 % 0 % -4.06 % 11.41 %
1 Year Return 566.32 % 19.8 % -34.83 % 0 % 52.52 % 73.07 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALGS VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.14 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -621.1 % -1.65 % 5.37 % -2.27 % -44.32 % -0.24 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
ALGS VRTX REGN SGEN ARGX ALNY
Asset Growth -53.74 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth -68.34 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth -74.6 % 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year 475.78 % 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year - 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year - 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth -1.17 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth -49.65 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share -550.47 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share -778.89 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share -3082.54 % 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth -1.17 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) -2.21 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG -344.13 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -504.41 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG -4410.97 % 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth -494.89 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth -494.89 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share -224.93 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share -199.78 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share -56.31 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share -612.2 % 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth -24.81 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth -2.35 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ALGS VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 67.45 % 86.09 % 84.47 % 72.37 % 46.33 % 85.62 %
Return on Assets TTM -187.19 % -2.38 % 11.69 % -11.76 % 13.45 % -6.56 %
Return on Equity TTM -354.27 % -3.28 % 14.77 % -16.53 % 16.83 % 905.33 %
Return on Capital Employed TTM -184.37 % -1.3 % 10.89 % -16.87 % -0.31 % -5.79 %
Net Income Per EBT TTM 100.25 % -215.53 % 92.32 % 100.55 % 25990.14 % 73.71 %
EBT Per Ebit TTM 146.8 % -100.69 % 118.85 % 94.01 % -18.79 % 213.34 %
EBIT Per Revenue TTM -2259.92 % -2.24 % 28.32 % -36.09 % -0.77 % -7.87 %
Cash Flow To Debt Ratio TTM -964.1 % -28.16 % 222.76 % -185.98 % -201.37 % -0.64 %
Receivables Turnover TTM - 6.84 2.29 1.98 2.46 5.55
Payables Turnover TTM 0.5 3.71 2.79 1.54 1.83 3.66
Inventory Turnover TTM - 1.27 0.71 0.65 2.93 4.12
Fixed Asset Turnover TTM 53.85 % 425.82 % 308.76 % 256.83 % 5106.8 % 323.99 %
Asset Turnover TTM 5.63 % 48.84 % 37.61 % 34.46 % 35.83 % 53.02 %
Operating Cash Flow Per Share TTM -12.89 -1.91 41.08 -1.12 -1.07 -0.06
Free Cash Flow Per Share TTM -12.91 -3.07 33.43 -1.62 -1.09 -0.33
Cash Per Share TTM 908.9 % 2375.11 % 16647.4 % 657.5 % 4597.04 % 2095.42 %
Operating Cash Flow Sales Ratio TTM -2046.72 % -4.48 % 31.13 % -16.85 % -3.54 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.16 % 160.43 % 81.38 % 144.14 % 102.26 % 512.38 %
Cash Flow Coverage Ratios TTM -964.1 % -28.16 % 222.76 % -185.98 % -201.37 % -0.64 %
Price To Free Cash Flows Ratio TTM -0.62 -165.4 18.25 -141.85 -453.07 -827.74
Price To Operating Cash Flows Ratio TTM -0.64 -266.09 14.86 -203.89 -540.97 -4192.79
Price Cash Flow Ratio TTM -0.64 -266.09 14.86 -203.89 -540.97 -4192.79
Income Statement (TTM)
ALGS VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.09B $0.49B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.13B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -20.94 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
ALGS VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.04B $0.03B $0B
Total Liabilities $0.1B $6.12B $8.41B $0.87B $0.68B $4.17B
Total Equity $-0.03B $16.41B $29.35B $2.8B $5.31B $0.07B
Total Investments $0.02B $6.65B $6.52B $1.42B $1.82B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.07B $22.53B $37.76B $3.67B $5.99B $4.24B
Cash Flow Statement (TTM)
ALGS VRTX REGN SGEN ARGX ALNY
Net Income $-0.13B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 21.01
ABCL AbCellera Biologics Inc. 2.09
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.5
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.972
ABPWW 0.044
ABSI Absci Corporation 2.28
ABUS Arbutus Biopharma Corporation 3.235
ABVC ABVC BioPharma, Inc. 0.7421
ABVX Abivax SA American Depositary Shares 5.235
ACAD ACADIA Pharmaceuticals Inc. 15.37
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6343
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.172
ACIU AC Immune SA 1.65
ACLX Arcellx, Inc. 58.51
ETFs With Exposure to ALGS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 248.53
IBB iShares Biotechnology ETF 0 117.06
SCHA Schwab U.S. Small-Cap ETF 0.000494831 21.185
VHT Vanguard Health Care Index Fund 0 245.13
BIB ProShares Ultra Nasdaq Biotechnology 0 40.41
VXF Vanguard Extended Market Index Fund 0 155.29
IWC iShares Micro-Cap ETF 0.00379 101.12
VFLQ Vanguard U.S. Liquidity Factor ETF 0.1 99.7611
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.76
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.75
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.01 33.96
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 45.73
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 45.72
VBINX Vanguard Balanced Index Fund Investor Shares 0 45.73
GERM ETFMG Treatments, Testing and Advancements ETF 0.08 19.1577
DFAU Dimensional US Core Equity Market ETF 0.00002626 34.72
IBBQ Invesco Nasdaq Biotechnology ETF 0 19.49
DFAT Dimensional U.S. Targeted Value ETF 0.00010431 46.4
DFAS Dimensional U.S. Small Cap ETF 0.00036208 54.18
VTSAX Vanguard Total Stock Market Index Fund 0 128.49
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 5.795
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 124.4
VITSX Vanguard Total Stock Market Index Fund 0 128.5
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000792912 90.54
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 124.41
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 129.64
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 43.88
VEMPX Vanguard Extended Market Index InstlPlus 0 306.98
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 241.06
Unlock